Executive summary

Based on the data of 261 patients with VS treated with stereotactic radiosurgery/hypofractionated stereotactic radiotherapy (SRS/HFSRT),  this study reported at 12 months LC of 99.5% and the hearing preservation rate of 97% with no statistical difference among the groups. The authors concluded that SRS/HFSRT, FRT and FPT for VS showed similar overall clinical and functional outcomes. 

Key content topics
Top cancer treatments